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A recent study systematically characterized the distribution of the long formof the leptin receptor
(LepRb) in the mouse brain and showed substantial LepRb mRNA expression in the nonpregan-
glionic Edinger-Westphal nucleus (npEW) in the rostroventral part of the midbrain. This nucleus
hosts themajority of urocortin 1 (Ucn1) neurons in the rodent brain, and because Ucn1 is a potent
satiety hormone and electrical lesioning of the npEW strongly decreases food intake, we have
hypothesized a role of npEW-Ucn1 neurons in leptin-controlled food intake. Here, we show by
immunohistochemistry thatnpEW-Ucn1neurons in themousecontainLepRbandrespondto leptin
administrationwith inductionof the Januskinase2-signal transducerandactivatorof transcription
3pathway,both in vivoand in vitro. Furthermore, systemic leptinadministration increases theUcn1
contentof thenpEWsignificantly,whereas inmice that lackLepRb (db/dbmice), thenpEWcontains
considerably reduced amount of Ucn1. Finally, we reveal by patch clamping of midbrain Ucn1
neurons that leptin administration reduces the electrical firing activity of the Ucn1 neurons. In
conclusion, we provide ample evidence for leptin actions that go beyond leptin’s well-known
targets in the hypothalamus and propose that leptin can directly influence the activity of the
midbrain Ucn1 neurons. (Endocrinology 152: 979–988, 2011)
Energy homeostasis requires tight regulation of foodintake and fat storage (e.g. see Refs. 1–3). A very crit-
ical hormone is leptin, the product of ob gene and pro-
duced by adipocytes. It conveys information to the brain
about the amountofperipherally stored fat (4). Leptin acts
through the leptin receptor long form (LepRb), the prod-
uct of db gene (5, 6), to activate the Janus kinase 2 (JAK2)-
signal transducer andactivatorof transcription3 (STAT3)
pathway (7, 8). It has been primarily shown to act in the
hypothalamus, especially on the arcuate nucleus, and it
plays a key role in the regulation of food intake and energy
expenditure (9, 10). However, some evidence is appearing
that leptin would also have direct effects on brain centers
outside the hypothalamus. For example, LepRb expres-
sion has been shown in the cerebral cortex, hippocampus,
midbrain, and brain stem (11). In a recent study, using a
novel LepRb-internal ribosomal entry site (IRES)-Cre-en-
hanced yellow fluorescent protein-reporter mouse and in
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situ hybridization, substantial amounts of LepRb expres-
sions were found in extrahypothalamic brain areas in adult
mice (12,13), suchas in thenonpreganglionicEdinger-West-
phal nucleus (npEW) in the rostroventral part of the mid-
brain. This nucleus is of particular interest, because its elec-
trical lesioning substantially decreased general food intake
(14) and this nucleus is the major source of urocortin 1
(Ucn1),amemberof thecorticotropinreleasing factor family
that has strong anorexigenic actions (15–17).
Recently, we showed that the rat npEW reveals sub-
stantial LepRbmRNA expression and responds to fasting
(18). Moreover, the npEW of rats fed a high-fat diet
showed a decrease in Ucn1 mRNA expression (19). In
addition, peripheral injection of low doses of Ucn1 pro-
duces strong and prolonged inhibition of food intake (20,
21), an effect that can also be seen in leptin-deficient (ob/
ob) mice (22). Intracerebroventricular (icv) administra-
tion of Ucn1 also potently reduces food intake in food-
deprived rats (23), an action most probably mediated by
the ventromedial hypothalamic nucleus (24).
The colocalization of LepRb and Ucn1 in npEW neu-
rons is interesting, because anumberof experimental stud-
ies have shown the interactions of leptin andUcn1on food
intake: 1) the satiety effect of Ucn1 is enhanced by its own
ability to induce plasma leptin (25), 2) cotreatment with
doses of leptin and Ucn1 that are ineffective while given
alone effectively suppresses appetite (26), 3) leptin facili-
tates Ucn1 transport across the blood-brain barrier (27),
and 4) Ucn1 seems to potentiate leptin signaling by leptin
receptor-mediated STAT3 phosphorylation (27).
Although these data taken together indicate that the
collaboration of peripheral leptin signaling and Ucn1 in
the npEW may play an important role in regulating feed-
ing behavior, the mechanism by which leptin would in-
fluence the activity of the npEW-Ucn1 neurons is unclear.
Here, we hypothesize that in mouse, leptin-mediated
signaling occurs in Ucn1 neurons in the npEW and that





mice were used. In vivo experiments were performed with
young-adult mice (10–12 wk old; obtained from The Jackson
Laboratory, Bar Harbor, ME) and housed in the University of
Texas Southwestern Medical Center at Dallas (in situ hybrid-
ization) or in the Unit for Laboratory Animal Medicine at the
University of Michigan (immunohistochemistry) in groups of
two to four unless stated otherwise. In vitro studies were per-
formed with wild-type (WT) C57BL/6J pups (16–21 d old),
housed with their mother, who was obtained from Janvier (Le-
Genest-St-Isle, France), in the Central Animal Laboratory at
Radboud University Nijmegen. They were all housed at a 12-h
light, 12-h dark cycle (lights on at 0600 h) in a humidity- and
temperature (22 C)-controlled environment and had access to
food and water ad libitum. All animal procedures had the ap-
proval of the respective University care and use committees.
Production of LepRbEGFP mice
To identify LepRb-expressing neurons, Leprcre mice were
crossed with RosaEGFP reporter mice to produce LepRbEGFP
offspring with enhanced green fluorescent protein (EGFP) ex-
pressed in LepRb neurons. Briefly, in Leprcre mice, an IRES-
driven second cistron encoding cre recombinase is “knocked in”
to the 3-untranslated region of the LepRb-specific exon ofLepr,
rendering the cre-coding sequence part of the LepRb-specific
mRNA such that its expression is restricted to LepRb-expressing
neurons (28). The Gt(ROSA)26Sortm2Sho (ROSAEGFP) line
from The Jackson Laboratory has been engineered such that
cre-mediated deletion of a floxed transcription-blocking cassette
results in the expression of EGFP from the ubiquitously ex-
pressedROSA26 locus (29). Because IRES-mediated cre expres-
sion is modest, mice were bred to homozygosity (Leprcre/cre,
RosaEGFP/EGFP) to enhance the detection of LepRb neurons by
EGFP expression. All matings were carried out in the University
of Michigan Unit for Laboratory Animal Medicine.
Peptide and antisera
Recombinant mouse leptin was obtained from the National
Hormone and Peptide Program (A. F. Parlow, Los Angeles, CA),
rabbit anti-Ucn1was a generous gift fromW.W.Vale (no. 5779;
The Salk Institute, La Jolla, CA), chicken anti-EGFP (no. 13970)
was fromAbcam (Cambridge,MA), rabbit antiphosphorylation
of STAT3 (pSTAT3) (no. 9131) fromCell Signaling Technology
(Danvers, MA), mouse antiglial fibrillary acidic protein (GFAP)
(no. GA-5) from ICN Biomedicals (Irvine, CA), goat anti-Ucn1
(no. sc-1825) from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA), andAlexa488-conjugatedgoat antichickenandAlexa594-
conjugated donkey antirabbit from Invitrogen (Carlsbad, CA).
Normal donkey serum and the Cy2-conjugated donkey-anti-
chicken, Cy2-conjugated donkey-antigoat, Cy3-conjugated don-
key-antirabbit, and Cy5-conjugated donkey-antimouse sera
were from Jackson ImmunoResearch (West Grove, PA). All
other immunolabeling supplies were purchased from Sigma
Chemical (St. Louis, MO).
Tissue preparations
Invivo studywith in situhybridization (LepRbmRNA)
Four C57BL/6J male mice were deeply anesthetized with an
ip injection of chloral hydrate (350 mg/kg) and perfused tran-
scardially with diethylpyrocarbonate (DEPC)-treated 0.9% sa-
line followed by 10% neutral buffered formalin. After decapi-
tation, brains were removed, postfixed in 10% neutral buffered
formalin for 4 h at 4 C, cryoprotected in 20% sucrose in DEPC-
treated PBS (pH7.0) overnight at 4C, and cut coronally into five
equal series of 25-M sections on a freezing microtome, which
were stored at20 C in antifreeze solution (30) until processing
for radioactive in situ hybridization.
In vivo studies with immunohistochemistry
The untreated LepRbEGFP mice were used to demonstrate
LepRb protein. To study the effect of leptin on Ucn1 in the
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npEW, 16 LepRbEGFP mice were single housed and injected ip
with either leptin (5 mg/kg) or equal volume vehicle (sterile PBS,
pH 7.4) and killed 2 or 4 h later. To assess the effect of disrupted
leptin signaling on the npEW, five db/db and fiveWTmice were
studied. All mice were deeply anesthetized with ip sodium pen-
tobarbital (150 mg/kg), transcardially perfused with ice-cold
PBS followed by 4% paraformaldehyde (PFA), for 30 min, de-
capitated, andbrains removed andpostfixed in 4%PFA (31), for
16 h. Four representative series of coronal sections (30m)were
cut with a sliding microtome, into a cryoprotective solution
(30% ethylene glycol, 30% glycerol; in PBS), and stored at20
C until use for immunohistochemistry.
In vitrobrain-slice studywith immunohistochemistry
Twelve C57BL/6J pups were decapitated, their brains were
quickly removed and placed into ice-cold slicing medium con-
taining 83.5 mM NaCl, 30 mM KCl, 1.3 mM KH2PO4, 1.2 mM
MgCl2, 2.4 mM CaCl2, 2.6 mM NaHCO3, 2.5 mM glucose, and
1.0 mM HEPES (pH 7.4) (Merck Chemical, Darmstadt, Ger-
many). The olfactory bulb and cerebellum were removed, and
the remaining tissuewas glued onto the holding block of a slicing
chamberwith the cerebellumside pointingupward, floodedwith
the slicing medium, and 300-m coronal slices containing the
npEW (between Bregma 3.2 and 3.6 mm) (32) cut with a
VT1000S vibratome (Leica Microsystems, Wetzlar, Germany)
and kept submerged on a grid in room temperature artificial
cerebral spinal fluid (ACSF) containing 120 mM NaCl, 2.5 mM
NaHCO3, 3.5mMKCl, 1.25mMNaH2PO4, 1.3mMMgSO4, 2.5
mM glucose, and 2.5 mM CaCl2 (pH 7.4). Slices were incubated
with ACSF (controls) or with ACSF 100 nM leptin, for 30 min
at 35 C. Then they were fixed in 4% PFA, for 2 d at 4 C, and 10
25-m coronal sections at the midlevel of the npEWwere cut on
the freezing microtome (Microm GmbH, Walldorf, Germany)
for immunohistochemistry.
In situ hybridization
The in situ hybridization procedure was a modification of
that previously reported (11, 12). In short, sections were rinsed
with DEPC-PBS, for 1 h, and treated with 1% sodium borohy-
dride (Sigma Chemical) in DEPC-PBS, for 15 min, briefly rinsed
in 0.1 M tetrachlorammonium (pH 8.0), treated with 0.25%
acetic anhydride in 0.1 M tetrachlorammonium, for 10 min, and
rinsed in DEPC-treated 2 sodium chloride/sodium citrate
(SSC). Sections were incubated for 16 h at 57 C, with LepR
riboprobes, generated by in vitro transcription using 35S-labeled
uridine triphosphate as previously described (12) and diluted to
106 cpm/ml in a solution containing 50% formamide, 10 mM
Tris-HCl (pH8.0) (LifeTechnologies, Inc.-BRL,Bethesda,MD),
5 mg tRNA (Invitrogen), 10 mM dithiothreitol, 10% dextran
sulfate, 0.3 M NaCl, 1 mM EDTA (pH 8.0), and 1 Denhardt’s
solution (Sigma Chemical). Then they were rinsed four times in
4 SSC, and incubated in 0.002% ribonuclease (RNase) A
(Roche Applied Bioscience, Indianapolis, IN) diluted in a mix-
ture of 0.5 M NaCl, 10 mM Tris-HCl (pH 8.0) and 1 mM EDTA
(RNase buffer), for 30 min at 37 C. After another 30 min in
RNase buffer and two rinses at room temperature in 2 SSC, the
sectionswere rinsed three times in 50% formamide in 0.2 SSC,
for 10 min at 50 C, and rinsed 2 SSC at 50 C, 0.2 SSC at 55
C, and 0.2 SSC at 60 C, each rinse for 1 h. After rinsing twice
in 2 SSC at room temperature, sections were mounted on Su-
perFrost Plus slides (Fisher, Pittsburgh, PA), dehydrated in a
graded ethanol series, anddelipidated in chloroform.After rinses
in 100and95%ethanol, slideswere air-dried andplaced inx-ray
film cassettes with BMR-2 film (Kodak, Rochester, NY), for 2 d.
Next, they were dipped in NTB2 emulsion (Kodak), air-dried,
and stored in light-tight boxes at 4 C for 4 wk. Slides were de-
veloped with Kodak Dd-19 developer, counterstained with
thionin, dehydrated in ethanol, cleared in xylene, and
mounted with Permaslip. The high specificity of the probes
has been shown before (12).
Immunohistochemistry
Single immunolabeling of EGFP was performed on the non-
treated LepRbEGFP mice. Single immunolabeling of Ucn1 was
performed on the PBS/leptin injected LepRbEGFP mice (4 h) and
WT and db/db mice. Sections were treated with 0.5% Triton
X-100 in PBS, for 30min, blocked in 2%normal donkey serum,
for 1 h, and incubated in primary chicken anti-EGFP (1:1000),
goat anti-Ucn1 (1:100; PBS/leptin injected mice, 4 h), or rabbit
anti-Ucn1 sera (1:30,000; WT and db/db mice) overnight. This
was followed by a 2-h incubation with the secondary anti-
bodies Alexa 488-conjugated goat antichicken (1:200), Cy2-
conjugated antigoat IgG (1:100), or Cy3-conjugated antirab-
bit IgG (1:100).
Double immunolabeling of EGFPwithUcn1 orwith pSTAT3
was performed on control or PBS/leptin-injected LepRbEGFP
mice (2 h), respectively. For double immunolabeling of EGFP
and Ucn1, sections were processed as described for single im-
munolabeling but with incubation in a mixture of the chicken
anti-EGFP (1:2000) and rabbit anti-Ucn1 sera (1:30,000), for
16 h, and then in a mixture of Cy2-conjugated antichicken IgG
and Cy3-conjugated antirabbit IgG (1:100), for 2 h. For double
immunolabeling of EGFP and pSTAT3, sectionswere pretreated
sequentially in 3% H2O2 and 1% NaOH, for 20 min, 0.3%
glycine, for 10 min, and 0.03% sodium dodecyl sulfate, for 10
min, and processed as described above, with chicken anti-EGFP
(1:1000) and rabbit anti-pSTAT3 (1:500) sera for 16 h, and
Alexa 488-conjugated goat antichicken (1:200) and Alexa 594-
conjugated donkey antirabbit sera, respectively, for 2 h (1:200).
Triple immunolabeling of Ucn1, pSTAT3, and GFAP was per-
formed on in vitro brain slices. The same protocol for pSTAT3
immunohistochemistry was applied, with incubation in goat anti-
Ucn1 (1:100), rabbit anti-pSTAT3(1:400), andmonoclonalmouse
anti-GFAP (1:100) sera, for 16 h, and then in a mixture of Cy2-
conjugated antigoat IgG,Cy3-conjugated antirabbit IgG, andCy5-
conjugated antimouse IgG (1:100) sera, respectively, for 2 h.
Antibody characterization
The high specificities of chicken anti-EGFP (8, 19, 28),mouse
anti-GFAP (33), rabbit anti-pSTAT3 (12, 34), goat anti-Ucn1
(35, 36), and rabbit anti-Ucn1 (19, 36, 37) have been previously
reported. In addition, preabsorption of antibodies with the re-
spective synthetic peptides abolished immunostaining in the
mouse npEW, and omission of primary antisera completely pre-
vented immunoreaction in all cases.
Image analysis
Immunostainings were studied with a BX-51 bright field mi-
croscope with DP30BW camera (Olympus, Tokyo, Japan) or a
confocal laser scanning microscopy (Leica Microsystems TCS
SP2 AOBS system). For quantitative determinations of the
amounts of immunoreactive peptide in the npEW, two param-
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eters were determined: 1) the number of neuronal perikarya was
counted in four medial sections of the npEW, and 2) per
perikaryon, the specific immunoreactive signal density (SSD)
was measured in each of all perikarya present in these sections,
using ImageJ software (version 1.37;NIH, Bethesda,MD). Data
were corrected for background density outside the npEW, yield-
ing the SSD expressed in arbitrary units per perikaryon.
Electrophysiology
Brain slices ofWTC57BL/6J pups (thickness, 300 m)made
as described above were incubated in ACSF, at 37 C for 30 min,
and then stored 2–4 h at room temperature until use. Neurons
in the npEW, 100–300 m ventral to the periaqueductal gray,
were studied in the cell-attached patch-clamp mode, using an
EPC-9 patch-clamp amplifier with patchMaster software ver-
sion 2.20 (HEKA, Lambrecht/Pfaltz, Germany). Data were re-
corded at 10 kHz and filtered using a 12.9-kHz Bessel filter.
Patch pipettes with a resistance between 4 and 6 Mwere pulled
from Wiretrol II glass capillaries (Drummond Scientific Co.,
Broomall, PA) with a PP-83 pipette puller (Narishige Scientific
Instrument Laboratories, Tokyo, Japan). All solutionswere con-
tinuously carbogenized (5%CO2-95%O2), and the temperature
of the superfusate was controlled with an SH-27B in-line tem-
perature heater coupled to a TC-324B single channel heater con-
troller (Harvard Apparatus, Holliston, MA). Electrical activity
was recorded in the cell-attached patch voltage-clampmode at 0
mV pipette potential (38). Performing measurements in cell-at-
tachedmode preserved the cytoplasm, and in this configuration,
spontaneous firing activity was observed. Cell firing activity was
recorded in the form of action potential currents, which are the
first derivatives of action potentials and are mainly due to the
capacitive current (39).During recording, cellswere incubated in
ACSF, followed by ACSF containing 100 nM leptin, and finally
inACSF towashout leptin.During each incubation,which lasted
3 min, the interspike interval (ISI), i.e. the time between two
successive action currents, was averaged over all currents mea-
sured. The coefficient of variation (CV) was calculated as SD/
mean of ISI, according to Yang et al. (38).
Statistical analyses
Per experimental group, datawere expressed as themean SEM
andenteredinStudent’s t testafter tests fornormality(Shapiro-Wilk
test; seeRef. 40) andhomogeneityof variance (Bartlett’s2 test; 41)
( 5%).
Results
Expression of LepRb in npEW-Ucn1 neurons
First, we used in situ hybridization to study the presence
ofLepRbmRNAinC57BL/6Jmice.Sectionsof themidbrain
were hybridized with a long-form specific antisense LepRb
probe. In thenpEW,neuronalperikarya revealed substantial
labeling (Fig. 1A). No staining was seen in the npEWwhen
the sense LepRbprobewas used (data not shown).Next,we
applied single-labeling immunofluorescence histochemistry
to show the presence of LepRb protein in LepRbEGFP mice
(Fig. 1E). They revealed an almost continuous, boomerang-
shapedpopulationofEGFP-immunoreactive (EGFP-ir) neu-
rons in the midbrain, starting dorsomedially in the npEW,
continuing through the rostral linear raphe and ventral teg-
FIG. 1. Visualization of midbrain LepRb neurons. A, LepRb mRNA is present in the npEW by radioactive in situ hybridization. E, LepRb-expressing
neurons are revealed by EGFP-ir (green) in the midbrain of LepRbEGFP mice. B–D, EGFP-ir (green) (B) neurons are colocalized (yellow) (D) with Ucn1-
ir (red) (C) in the npEW of LepRbEGFP mice. Scale bar, 20 m (A–D) and 100 m (E). Aq, Central aqueduct; III, nucleus of oculomotor nerve; IPF,
fasciculus interpeduncularis; PAG, periaqueductal gray; RLi, rostral linear nucleus; SC, colliculus superior; SNC, substantia nigra pars compacta;
SNR, substantia nigra reticular part.
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mental area (VTA), and terminating with a few scattered
neurons inthesubstantianigraparscompacta.Usingdouble-
labeling immunofluorescence, we showed in npEWneurons
thecoexistenceofEGFP-irwithUcn1-ir (Fig.1,B–D).Nearly
all (90%) EGFP-ir neurons revealed Ucn1-ir, whereas
about 45% of the Ucn1-ir neurons were EGFP-ir (Fig. 1D).
Noneof theEGFP-positiveneurons in the linear raphe,VTA,
and substantia nigra pars compacta showed Ucn1-ir (data
not shown). One limitation of the genetic model used in this
study is that not all of the LepRbneuronswill exhibit EGFP-
ir,becauseonlyasubpopulationofLepRbneuronsexpresses
EGFP-ir (19, 42).
LepRb signaling increases STAT3 phosphorylation
Toassesswhether LepRb in the npEW is functional, the
JAK2-STAT3 pathway was evaluated. This signaling
pathway is induced when leptin binds to LepRb, resulting
in pSTAT3. Subsequently, the pSTAT3 is translocated
into the nucleus tomediate gene transcription (43, 44). To
determinewhether leptin stimulates pSTAT3 in the npEW
in vivo, LepRbEGFP mice were ip injected with PBS or lep-
tin. Immunohistochemistry revealed no staining of
pSTAT3-ir anywhere in the midbrain 2 h after PBS injec-
tion (Fig. 2A). However, 2 h after leptin
administration, clear pSTAT3-ir was
seen to be colocalized with the EGFP-ir
neurons in the npEW (Fig. 2B). To as-
sess whether this stimulatory effect
would be due to a direct action of leptin
on the npEW, brain slices containing
the npEW were incubated in vitro with
leptin. In fresh, control slices, incubated
in ACSF, pSTAT3-ir was seen through-
out the tissue in GFAP-ir astrocytes.
This was not surprising, because the
mere preparation of brain slices is suf-
ficient to induce the JAK2-STAT3path-
way in astrocytes (42). Such fresh slices
never revealed any pSTAT3-ir in neu-
rons, including the Ucn1-ir neurons in
the npEW (Fig. 2C). However, in slices
incubated for 30min with ACSF 100
nM leptin, pSTAT3-ir was not only ob-
served in GFAP-ir astrocytes but also in
about 40% of the Ucn1-ir neurons,
which revealed strong labeling of nu-
cleus (triple labeling; Fig. 2D).
Leptin changes Ucn1 peptide
content in npEW neurons
Studying the effect of leptin on the
degree of Ucn1-ir of the npEW of
C57BL/6Jmice by semiquantitative im-
munohistochemistry revealed that, in leptin-injectedmice,
the number of Ucn1-ir cells was not different from that in
PBS-injected controls (P  0.05; n  5; PBS, 31.9  1.8;
Leptin, 28.6  2.4). However, the abundance of Ucn1-ir
per individual perikaryon, as assessed by measuring the
SSD, was significantly higher in leptin-injected mice than
in the controls (P 	 0.05; n  5) (Fig. 3, A, B, E, and F).
Next, we performed the same experimentwith db/dbmice
and their control littermates (WT). In the db/db mice, the
number of npEW-Ucn1-ir neurons and the SSDofUcn1-ir
were significantly lower (P	 0.0005 and P	 0.005; n
5, respectively) than in WT (Fig. 3, C, D, G, and H).
Leptin inhibits electrical activity of Ucn1 neurons
To determine the effect of leptin on electrical activity of
Ucn1-neurons in the npEW, cell-attached voltage-clamp
patch-clamp measurements were performed on brain
slices of C57BL/6J pups. All recorded neurons (n  11)
spontaneously displayed action current firing, with an ISI
of 0.37  0.08 sec (Fig. 4, A–C). When ACSF  100 nM
leptinwas used as superfusate, cells showed a reduction in
action current frequency (Fig. 4, A–C), reflected by an
FIG. 2. Increased STAT3 phosphorylation (pSTAT3) by leptin both in vivo and in vitro. A and
B, In vivo, systemic leptin administration (5 mg/kg ip, 2 h) of LepRbEGFP mice induces pSTAT3-
ir (red) in the npEW compared with PBS injection. The inset shows a high magnification of
colocalization of EGFP-ir (green) and nuclear pSTAT3-ir (red). C and D, In vitro, incubation
with ACSF on midbrain slices, pSTAT3-ir (red) is observed in GFAP-ir (blue) astrocytes (C);
incubation with leptin induces pSTAT3-ir (red) not only in GFAP-ir (blue) astrocytes but also in
the Ucn1-ir (green) neurons (D). Scale bar, 20 m.
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increase in the ISI by 32.9% (P 	 0.01; n  11) (Fig. 4,
A–C). In the majority of cells (n  9), this effect was re-
versible upon washing out leptin, returning the ISI to con-
trol value (0.39  0.07 sec; P 	 0.05)
(Fig. 4,A–C). To test the possibility that
leptin regulates the electrical activity of
npEW-LepRb neurons (see Discus-
sion), we performed patch-clamp elec-
trophysiology in acute brain slices with
direct leptin administration. Our data
demonstrates that leptin inhibits the
neurons’ electrical activity in approxi-
mately 80% of patched neurons. Of
two cells only, the leptin-effect could
not be reversed by leptin washout. In
contrast to its effect on the ISI, leptindid
never affect the CV (P  0.05; n  11)
(Fig. 4D). The recorded cells likely rep-
resent Ucn1 producing neurons, be-
cause the immunohistochemistry data
show that approximately 90%ofEGFP
neurons are Ucn1 neurons.
Discussion
Based on the expression of LepRb in the
npEW (12, 13, 18), we hypothesized
that the peripheral metabolic status
would directly modulate the activity of
the npEW via an action of leptin on
LepRb of npEW-Ucn1 neurons by re-
cruiting JAK-STATsignaling.Our find-
ings on the mouse npEW support this
hypothesis, for the following reasons:
1) LepRb is present in the npEW, and
nearly all LepRb-containing neurons
produceUcn1; 2) administration of lep-
tin either peripherally in vivoor directly
onto the npEW in vitro causes pSTAT3
in npEW-Ucn1 neurons; 3) leptin ad-
ministration significantly increases the
abundance of Ucn1 in npEW-neurons;
4) LepRb-deficient (db/db) mice con-
tain considerably less Ucn1 than WT
mice; and 5) leptin acutely reduces the
electrical activity of npEW-Ucn1 neu-
rons. Together, the present results re-
veal that leptin directly targets npEW-
Ucn1 neurons to modulate the activity
of these neurons, at both the short-term
(electrical response of Ucn1 neurons)
and long-term (abundanceofUcn1pep-
tide in npEW neurons) level. Below, we will discuss these
conclusions into detail.
FIG. 3. Regulation of Ucn1 content in the npEW by increased and disrupted leptin signaling. A
and B, Fluorescent immunohistochemistry reveals Ucn1-ir (green) in the npEW in PBS and leptin
injected mice (n 5). E and F, Systemic leptin administration (5 mg/kg ip, 4 h) of LepRbEGFP mice
increases SSD of Ucn1-ir significantly (F) but not the number of Ucn1-ir neurons (E). C and D,
Fluorescent immunohistochemistry reveals Ucn1-ir (red) in the npEW in WT and db/db mice (n
5). G and H, Both the number and SSD of Ucn1-ir neurons are decreased significantly in db/db
mice compared with WT. Scale bar, 20 m. *, P	 0.05; ***, P	 0.005.
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LepRb occurs in npEW-Ucn1 neurons
First, we demonstrated the production of LepRb by
npEW neurons by showing the expression of LepRb
mRNA with in situ hybridization, which is in agreement
with two recent, independent studies (12, 13). Next, we
detected the LepRbby applying immunohistochemistry to
a reporter mouse strain (LepRbEGFP mice) (19, 28, 45).
Our finding that EGFP-labeled LepRb neurons occur in a
characteristic, homogeneous, boomerang-shaped mid-
brain population of neurons, encompassing not only the
npEW but also the rostral linear raphe, the VTA, and the
substantia nigra pars compacta, is interesting, because
these anatomically distinct neuronal subgroups all origi-
nate from the midbrain floor plate (46). This shared phe-
notype and common origin of these midbrain nuclei sug-
gest an important coordinating role for leptin in the
midbrain.Although leptin’s actiononVTA (47, 48) iswell
documented, little is known about the hormone’s action
on othermidbrain LepRb expressing neurons andmore in
particular on LepRb expressing neurons in the npEW.
Therefore, and in view of the dominant presence of Ucn1
in the npEW, we tested whether leptin would act on Ucn1
dynamics in this nucleus and found that almost all npEW-
neurons that contain the LepRb also contain Ucn1 and
that, conversely, 45% of Ucn1 neurons in the npEW pro-
duceLepRb.This situation is similar to that forotherbrain
centers that are under physiological control by leptin. For
example, 47% of the NPY-neurons in the arcuate nucleus
and 60%of the dopaminergic neurons in theVTA express
LepRbmRNA (47, 49). This analogy supports the general
notion that even though brain centers may be anatomi-
cally distinctly structured, they may have many different
functions, some of which are associated with similar func-
tionsofotherbraincenters, in thiswayestablishingnetworks
of collaborating neurons that serve the coordination of the
various central regulations necessary tomaintain physiolog-
ical homeostasis.
Leptin recruits pSTAT3 in npEW neurons
In view of the capability of leptin to cross the blood-
brain barrier inmost parts of the brain (including themid-
brain) (50) and thepresenceof leptin receptors throughout
the brain (11–13), we tested whether leptin, by binding to
LepRb, would be able to induce direct response on the
npEW-Ucn1 neurons or whether additional input to these
neurons from remote brain centers would be necessary for
such leptin-mediated activation. For this purpose, we de-
prived the npEW from peripheral nervous input, by dis-
secting it out as a thin brain slice thatwas kept in vitro and
treated with leptin. STAT3-tyrosine phosphorylation was
used as a read-out parameter for npEW-Ucn1 neuron sig-
nal, because it represents response of the common leptin-
FIG. 4. Cell-attached patch-clamp recordings from the npEW neurons in voltage-clamp mode. A, Example of one neuron responding to leptin and
washout. B, Number of action current firing plotted with ISI of the neuron shown in A. C, Mean ISI increased by leptin application and reversed by
washout. D, The CV-value is not affected by leptin treatment. *, P 	 0.05; **, P 	 0.01.
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signaling JAK-STAT pathway (7, 8, 31). Because we
showed that acute leptin administration to such brain
slices induced within 30 min STAT3 phosphorylation in
many npEW-Ucn1-ir neurons, we conclude that leptin is
indeed able to activate these neurons directly, without the
support of neuronal input from remote brain centers. This
finding is likely relevant for the in vivo situation as well,
becausewe also found that systemic administration of lep-
tin induces pSTAT3 in npEW-LepRb neurons. Our ob-
servation of leptin-induced recruitment of Ucn1 neurons
in the npEW extends the recent report on leptin-induction
of STAT3 phosphorylation inmouse npEWneurons (13).
Because the JAK-STAT signaling pathway is a major sig-
naling alternative to the second messenger system and
transduces external neurochemical information to gene
promoters on nuclear DNA (8), our data indicate that
leptin may be involved in the control of (possibly Ucn1)
gene expression and/or Ucn1 biosynthesis.
Leptin regulates npEW Ucn1 production
Although the administration of exogenous leptin often
evokes only modest effects in normal animals, deficiency
in leptin signaling (e.g. lack of leptin receptor) promotes
marked alterations in neuronal function and mammalian
physiology. We show that peripheral injection of leptin
increases the abundance of Ucn1 within the npEW-Ucn1
neurons, whereas in db/db mice, the abundance was
strongly decreased. These results clearly show that leptin
regulates the Ucn1 content in npEW neurons and suggest
that although short-term action of leptin (as mimicked by
our injection study) evokes amoderate increase in cellular
Ucn1 content, long-term absence of leptin signaling (as
occurs in db/dbmice) leads to aprofounddecrease inUcn1
in the npEW.
Leptin inhibits electrical activity of npEW neurons
To test the possibility that leptin regulates the electrical
activity of npEW-LepRb neurons, we performed patch-
clamp electrophysiology in acute brain slices with direct
leptin administration. Our data demonstrates that leptin
inhibits the neurons’ electrical activity in approximately
80% of patched neurons. This finding is consistent with
the described action of leptin on the electrical activity of
the VTA (47), the dorsal vagal nucleus (51), the premam-
millary nucleus of the hypothalamus (45), the lateral hy-
pothalamic area (19), and the dorsal and ventral raphe
nucleus (52). Based on the fact that approximately 90%of
EGFPandpSTAT3positive neurons areUcn1positive and
the responses in the electrophysiological study, we argue
that the observed effects of leptin are through a direct
interaction of leptin via LepRb on the Ucn1 neurons, al-
though we cannot exclude a (although not very likely)
possible involvement of interneurons. The electrophysio-
logical response of the mouse npEW after leptin admin-
istration indicates that rapid signaling downstream of
LepRb is an important facet of leptin regulating the ac-
tivity of npEW neurons. Meanwhile, leptin’s ability to
induce STAT3 activation supports the idea that the mes-
sengermay control long-term (e.g. transcriptional) events,
such as (Ucn1) gene expression and Ucn1 biosynthesis
as well.
Based on the anorexigenic action of centrally adminis-
teredUcn1, onewould expect an increased release ofUcn1
from the npEW after leptin injection. Our results do not
support this expectation but are well in line with the facts
that lesioning the EW results in inhibition of food intake
(14) and that decreased leptin by starvation increases
Ucn1 mRNA in the rat npEW (18). In addition, high-fat
diet decreasesUcn1mRNA in the npEWtoo, concomitant
with increased plasma leptin level (53). Furthermore, the
physiological role(s) of a centrally administeredneuropep-
tide has always been difficult to interpret. Ucn1 adminis-
tered via an icv route has access to both corticotropin-
releasing factor receptor subtypes, which could lead to
differential (even opposing) behavioral, physiological,
and neuroendocrine responses. Central injection of Ucn1
not only reduces food intake (23) but also increases energy
expenditure (54), increases anxiety-like behavior (55–57),
and even improves learning and memory (58), suggesting
that the physiological role(s) of icv-injected Ucn1 will
highly depend on its concentration, its site of action, and
its binding with its cognate receptor(s). Taken together,
weargue that anegative correlation exists betweenplasma
leptin and Ucn1 specifically in the npEW.
Conclusion and possible functional
consideration
The relationship between leptin and the regulation of
short and long-term aspects of the activity of Ucn1 neu-
rons in the npEW, as emanate from the present studies,
support a notion that these neurons play an important role
in the processing of information about the metabolic sta-
tus of the animal. Interestingly, developmental studies of
midbrain (dopaminergic) neurons strongly suggest a com-
mon origin for midbrain LepRb neurons, including the
substantia nigra, VTA, rostral linear raphe nucleus, and
the npEW (19, 46). Regulation of the mesolimbic dopa-
mine system plays an important role in feeding behavior,
as well as in reward processing (59–61), and metabolic
status is an important modulator of such motivational
behaviors. It has been suggested that leptin, amajor signal
of long-term energy balance, canmodulate the response to
food and nonfood rewards via the mesolimbic dopami-
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nergic system (62). Although the VTA is a well-known
center modulating reward processing (59), as well as ex-
presses LepRb, in a recent study, Leshan et al. (63) have
found that LepRb VTA neurons represent a subclass of
VTA dopaminergic neurons that specifically innervate
and control the central amygdala and send only scarce
projections to the nucleus accumbens (63). This clearly
indicates that yet another population(s) of midbrain
LepRb neurons may play roles in mediating/controlling
reward processing. In support of such action, particularly
by the midbrain npEW-Ucn1/LepRb expressing neurons,
are the facts that these neurons are directly regulated by
leptin (this study) and that Ucn1’s ability to reduce food
intake was interestingly accompanied by a reduced moti-
vation to eat (64). This intriguing (inter)action of npEW-
Ucn1/LepRb is currently under investigation in our group.
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